Attenuated antibody responses to respiratory syncytial virus vaccination in hematologic malignancies: impact of anti-CD20 therapy

Yair Herishanu; Yotam Bronstein; Ora Halutz; Dana Gamzu; Chava Perry; Yael Cohen; Irit Avivi

doi:10.3324/haematol.2025.289242

Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Letters to the Editor

Attenuated antibody responses to respiratory syncytial virus vaccination in hematologic malignancies: impact of anti-CD20 therapy

Yair Herishanu
Yotam Bronstein
Ora Halutz
Dana Gamzu
Chava Perry
Yael Cohen
Irit Avivi

Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Gray Faculty of Medical and Health Sciences Tel-Aviv University, Tel-Aviv

Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv

Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Gray Faculty of Medical and Health Sciences Tel-Aviv University, Tel-Aviv

Haematologica Early view Jan 8, 2026 https://doi.org/10.3324/haematol.2025.289242

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor

DOI

https://doi.org/10.3324/haematol.2025.289242

Published

2026-01-08

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views

PDF Downloads

Statistics from Altmetric.com

No Data

Attenuated antibody responses to respiratory syncytial virus vaccination in hematologic malignancies: impact of anti-CD20 therapy

Abstract

Figures & Tables

Article Information

Article Usage

Statistics from Altmetric.com

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More